Can a new lens give sharper sight at all distances?

NCT ID NCT06111222

Completed Disease control Sponsor: Carl Zeiss Meditec AG Source: ClinicalTrials.gov ↗

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This trial investigates how well a new multifocal intraocular lens, the AT ELANA, improves vision in people having cataract or refractive lens exchange surgery. About 69 participants will receive the lens in both eyes and be followed for 12 months to measure visual sharpness and satisfaction. The goal is to see if the lens provides clear vision at near, intermediate, and far distances, potentially reducing dependence on glasses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a multifocal intraocular lens called AT ELANA
What this could lead to: If successful, this lens could provide clearer vision at multiple distances, reducing the need for glasses after cataract or lens exchange surgery.
What could go wrong: This is a small, non-randomized study with no control group, so results may not apply broadly. Some patients may experience glare or halos with multifocal lenses.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT REFRACTIVE LENS EXCHANGE

Contacts and locations

Show contact details

Locations

Ofatlivist Alicante

Alicante, 03001, Spain
PVK Precise Vision GmbH

Rheine, 48429, Germany
Universitätsklinikum Heidelberg

Heidelberg, 69120, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.